🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2016-08-26
Trial ID
NCT02793856
Treatments Being Tested
This clinical trial aims to investigate the safety, optimal dosage, and eff...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-09-01
Trial ID
NCT06559644
Treatments Being Tested
Single-patient trial aiming to provide immunological consolidation followin...
Status
Completed
Location
Ciusss-Emtl
Start Date
2024-01-16
Trial ID
NCT06391814
Treatments Being Tested
This Phase I dose-escalation trial is designed to evaluate the safety of ra...
Status
Active Not Recruiting
Location
Childrens National Medical Center
Start Date
2017-02-15
Trial ID
NCT03180216
Treatments Being Tested
The purpose of this study is to investigate the safety and therapeutic effe...
Status
Unknown
Location
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Start Date
2016-10
Trial ID
NCT02932826
Treatments Being Tested
This clinical trial will explore the safety and effect of autologous ex viv...
Status
Completed
Location
Rady Children's Hospital
Start Date
2016-02
Trial ID
NCT02691247
Treatments Being Tested
A Phase II safety and tolerability study of expanded gamma delta T cell lym...
Status
Withdrawn
Location
Royal Victoria Infirmary
Start Date
2021-12-13
Trial ID
NCT04834128
Treatments Being Tested
This study aims to evaluate the safety, tolerability and efficacy of ex-viv...
Status
Unknown
Location
Beijing 302 Hospital of China
Start Date
2020-08-15
Trial ID
NCT04518774
Treatments Being Tested
This phase I trial studies the safety and the ability to expand laboratory-...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2003-06
Trial ID
NCT00228358